Tepotinib price at a glance: How much does it cost per box? How much does it cost after medical insurance?

Tepotinib (Tepotinib), as a targeted therapy for metastatic non-small cell lung cancer with MET exon 14 skipping mutations, has attracted much attention for its clinical efficacy. However, it is equally important for patients to know the price information of tepotinib. This article will give you a detailed introduction to the prices of Tepotinib’s original drug and generic drugs, as well as the cost after medical insurance.

1. The price of original research drugs is high

The price of Tepotinib’s original drug is relatively high, and the price of one box (usually 225mg*60 tablets) can reach more than 30,000 yuan. Such a price is undoubtedly a significant burden for many patients, limiting the accessibility of the drug.

2. Generic drugs are more affordable

In order to alleviate the financial pressure on patients, multiple generic versions of tepotinib have appeared on the market. Among them, the price of a box of the Lucius version of the generic medicine is about more than 7,000 yuan, while the price of the ASEAN version is slightly higher, close to 9,000 yuan per box. Although the price of these generic drugs is still high, it has dropped significantly compared with the original drugs, providing the possibility of treatment for more patients.

3. Not yet included in medical insurance

Unfortunately, tepotinib has not yet been included in the national medical insurance directory. This means that patients need to pay for it themselves and cannot enjoy reimbursement by medical insurance. This undoubtedly increases the financial burden for patients who require long-term treatment.

To sum up, tepotinib, as an important targeted therapy drug, plays an irreplaceable role in the field of anti-cancer. However, high prices and lack of coverage in medical insurance limit its accessibility. It is expected that as medical policies continue to improve in the future, the price of tepotinib can be gradually reduced and included in the medical insurance list, so that more patients can afford this highly effective treatment drug.